alexa Synthesis, Characterization And Pharmacological Evaluation Of Hybrid Urea/thiourea Derivative As A Potential Antidiabetic Activity
ISSN: 2376-0419

Journal of Pharmaceutical Care & Health Systems
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading Please wait..

10TH Asia-Pacific Pharma Congress
May 08-10, 2017 Singapore

Tanmoy Guria, Puspita Roy and Tapan kumar Maity
Jadavpur University, India
Posters & Accepted Abstracts: J Pharma Care Health Sys
DOI: 10.4172/2376-0419-C1-021
The prevalence of diabetes is rising all over the world due to population growth, aging, urbanization and an increase in obesity and physical inactivity. Type 2 Diabetes mellitus (T2DM) presents a major challenge to healthcare system around the world. Urea and thiourea derivatives possess many promising biological activities. Here, urea/thiourea derivatives have been synthesized and screened for the antidiabetic activity. This study involves the synthesis of a series of hybrid urea/thiourea derivatives (5a-5h) containing chalcone moiety. The synthesized compounds were characterized by FT-IR, 1H NMR, mass spectroscopy and evaluated for their both in vitro and in vivo antidiabetic activity. The in vitro antidiabetic activity was done by α-glucosidase inhibitory activity of synthesized compounds. Acute toxicity study of the synthesized compounds was conducted by OECD guidelines, from which dose levels were calculated. The in vivo antidiabetic activity was performed on streptozotocin induced diabetic Swiss albino rats. The blood glucose level, different enzymatic studies (SGPT, SGOT, ALT) and lipid profile (HDL, LDL, Cholesterol) of the studied animal were estimated. The results indicated that the hybrid urea/thiourea derivatives displayed promising antidiabetic activity. Among the series, compound 5a showed potent α-glucosidase inhibitory activity when compared to the standard drug Acarbose. In in vivo study, the compound 5a was found more effective when compared to the standard drug Metformin. It may be concluded that hybrid urea/ thiourea derivatives will be a new class of antidiabetic compound in future.

Email: [email protected]

image PDF   |   image HTML

Relevant Topics

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version